Similarly, DEPDC1B SHCBP1, RRM2, PLK1, and UHRF1 have been found to promote melanoma proliferation and could be potential targets for treatment [48–52]; their coefficients were all positive, which implies that they had an additive effect on the risk scores. The gene discussed is PLK1; the disease is melanoma.